Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Greater Cannabis CO Inc (GCAN)

Greater Cannabis CO Inc (GCAN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 0.00
  • Price/Book 0.00
Trade GCAN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0005 +40.00%
on 04/23/24
0.0008 -12.50%
on 04/11/24
unch (unch)
since 03/22/24
3-Month
0.0004 +75.00%
on 03/12/24
0.0009 -22.22%
on 02/07/24
+0.0001 (+16.67%)
since 01/23/24
52-Week
0.0003 +133.33%
on 05/10/23
0.0015 -53.33%
on 11/24/23
+0.0001 (+16.67%)
since 04/21/23

Most Recent Stories

More News
GCANRx Strategic Advisor Dr. Adi Aran to be Interviewed by Dr. Sanjay Gupta on CNN Cannabis Special

The 6th Installment in the Award-winning Series by Dr. Sanjay Gupta will Air on Sunday, December 19th at 9pm ET BALTIMORE, Dec. 16, 2021 (GLOBE...

GCAN : 0.0007 (+16.67%)
GCANRx Appoints Renowned Cannabinoid Researcher Dr. Adi Aran as Strategic Advisor

Dr. Aran will be focused on furthering development of the therapeutic pipeline, advancing the clinical study program and supporting IP and regulatory...

GCAN : 0.0007 (+16.67%)
GCANRx Announces Initiation of Preclinical Study for Neuropsychiatric Cannabinoid Therapy

BALTIMORE, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company...

GCAN : 0.0007 (+16.67%)
GCANRx Signs Licensing Agreement with Shaare Zedek Scientific for Innovative Neuropsychiatric Cannabinoid Therapy

BALTIMORE, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTCQB: GCAN) a cannabis innovator specializing in the development of pharmaceutical and...

GCAN : 0.0007 (+16.67%)
GCANRx Announces Collaboration with Renowned Cannabis Research Lab

BALTIMORE, March 16, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Company  ( OTCQB: GCAN ), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid products...

GCAN : 0.0007 (+16.67%)
The Greater Cannabis Company Announces Relisting to OTCQB

BALTIMORE, March 09, 2021 (GLOBE NEWSWIRE) -- The Greater Cannabis Company, Inc. (OTCQB: GCAN) (“the Company”), a biopharmaceutical company focused on development and commercialization of innovative...

GCAN : 0.0007 (+16.67%)
Greater Cannabis To Present at the Benzinga Cannabis Capital Conference

BALTIMORE, MD, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Co. (OTC: GCAN), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid products is...

GCAN : 0.0007 (+16.67%)
Greater Cannabis Company Announces Retirement of Remaining Convertible Debt

BALTIMORE, MD, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The Greater Cannabis Company ( GCAN ), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid products...

GCAN : 0.0007 (+16.67%)
The Greater Cannabis Company Announces Launch of Bob Ross Beauty and Cosmetics Products

Initial products to launch in Party City and online through e-tailer network for holiday season

GCAN : 0.0007 (+16.67%)
Greater Cannabis Partners with Leading Beauty Brand, Cinema Secrets

Collaboration will Focus on Development of Innovative CBD Health and Beauty Products

GCAN : 0.0007 (+16.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Gammacan International, Inc. was incorporated under the laws of the state of Delaware on October 6, 1998 under the name of San Jose International, Inc. On August 19, 2004, the Company changed the name of its company to Gammacan International, Inc. in the State of Delaware. With the acquisition of the...

See More

Key Turning Points

3rd Resistance Point 0.0010
2nd Resistance Point 0.0008
1st Resistance Point 0.0008
Last Price 0.0007
1st Support Level 0.0006
2nd Support Level 0.0004
3rd Support Level 0.0004

See More

52-Week High 0.0015
Fibonacci 61.8% 0.0010
Fibonacci 50% 0.0009
Fibonacci 38.2% 0.0008
Last Price 0.0007
52-Week Low 0.0003

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar